Development Level

Tbio 80 | 10,625
Tdark 6 | 7,003
Tchem 5 | 1,890

Disease

ovarian cancer 30 | 8,484
lung cancer 28 | 4,466
intraductal papillary-mucinous neoplasm (IPMN) 26 | 3,289
diabetes mellitus 25 | 1,663
Diamond-Blackfan anemia 23 | 28
Multiple myeloma 22 | 1,327
medulloblastoma, large-cell 20 | 6,234
sonic hedgehog group medulloblastoma 15 | 1,482
Waldenstrons macroglobulinemia 14 | 765
osteosarcoma 14 | 7,933
Anemia, Diamond-Blackfan 13 | 15
intraductal papillary-mucinous adenoma (IPMA) 12 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 11 | 2,988
acute quadriplegic myopathy 10 | 1,157
cystic fibrosis 10 | 1,665
psoriasis 10 | 6,685
Stomach Neoplasms 9 | 282
atypical teratoid / rhabdoid tumor 9 | 4,369
Disease Progression 8 | 125
oligodendroglioma 8 | 2,849
Anemia 7 | 252
Mammary Neoplasms 7 | 410
acute myeloid leukemia 7 | 780
glioblastoma 7 | 5,572
invasive ductal carcinoma 7 | 2,950
malignant mesothelioma 7 | 3,162
Cancer 6 | 2,346
colon cancer 6 | 1,475
inflammatory breast cancer 6 | 404
mucosa-associated lymphoid tissue lymphoma 6 | 480
subependymal giant cell astrocytoma 6 | 2,287
Breast cancer 5 | 3,094
adult high grade glioma 5 | 2,148
astrocytoma 5 | 1,493
group 3 medulloblastoma 5 | 2,254
lung adenocarcinoma 5 | 2,713
pilocytic astrocytoma 5 | 3,086
primitive neuroectodermal tumor 5 | 3,031
Animal Mammary Neoplasms 4 | 136
Mammary Neoplasms, Experimental 4 | 150
Parkinson Disease 4 | 102
glioblastoma multiforme 4 | 347
non-small cell lung cancer 4 | 2,798
Duchenne muscular dystrophy 3 | 602
Irregular astigmatism 3 | 11
Neoplasm Invasiveness 3 | 127
Polycystic Ovary Syndrome 3 | 332
Prostatic Neoplasms 3 | 471
Pure red-cell aplasia 3 | 4
Weight Gain 3 | 87
adrenocortical carcinoma 3 | 1,427
atypical teratoid/rhabdoid tumor 3 | 1,095
cutaneous lupus erythematosus 3 | 1,056
ependymoma 3 | 2,514
pancreatic cancer 3 | 2,300
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,795
pediatric high grade glioma 3 | 2,712
posterior fossa group A ependymoma 3 | 1,511
Anoxia 2 | 33
Babesiosis 2 | 13
Bowen-Conradi syndrome 2 | 16
Brucellosis 2 | 24
Diamond-Blackfan Anemia With Microtia And Cleft Palate 2 | 3
Esophagus squamous cell carcinoma 2 | 3
Lacrimal gland carcinoma 2 | 5
Lymphoid leukemia 2 | 69
Melanotic neuroectodermal tumor 2 | 7
Mesenchymal chondrosarcoma 2 | 4
Osteoporosis 2 | 257
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 | 18
Renal Cell Carcinoma 2 | 199
Rheumatoid Arthritis 2 | 1,160
Shwachman-Diamond syndrome 2 | 16
Spondylolysis 2 | 9
Spondylosis 2 | 13
Theileriasis 2 | 13
Treacher Collins syndrome 2 | 29
Turner syndrome 2 | 31
Tyrosinemia type I 2 | 3
astrocytic glioma 2 | 2,241
breast carcinoma 2 | 1,614
dermatomyositis 2 | 933
juvenile dermatomyositis 2 | 1,189
lung carcinoma 2 | 2,844
medulloblastoma 2 | 1,524
non diabetic and post-ischemic heart failure 2 | 200
primary pancreatic ductal adenocarcinoma 2 | 1,271
ulcerative colitis 2 | 2,087
Amnestic disorder 1 | 37
Chromosome 2p16.1-p15 deletion syndrome 1 | 6
Lymphocele 1 | 7
Nephritis 1 | 29
Newcastle disease 1 | 13
Ovarian Cysts 1 | 34
Pick's disease 1 | 14
Scoliosis 1 | 40
Scrapie 1 | 15
Sertoli cell-only syndrome 1 | 36
Transient cerebral ischemia 1 | 14
Vesicoureteral reflux 1 | 28

Tissue

Blood and immune system 91 | 17,995
Cardiovascular System 91 | 17,958
Digestive Tract 91 | 18,473
Endocrine System 91 | 18,512
Female tissues 91 | 18,647
Liver and Pancreas 91 | 18,136
Male tissues 91 | 17,969
Nervous System 91 | 18,561
Respiratory system 91 | 17,484
Urinary Tract 91 | 18,444
Skin and soft tissues 89 | 18,115

Target Family

Non-IDG 91 | 11,971

Reactome Pathway

Peptide chain elongation 91 | 91
Signal Transduction 2,516 | 2,516
Immune System 2,184 | 2,184
Metabolism 2,132 | 2,132
Gene Expression 1,755 | 1,755
Metabolism of proteins 1,545 | 1,545
Innate Immune System 1,376 | 1,376
Signaling by GPCR 1,330 | 1,330
Developmental Biology 1,029 | 1,029
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,005 | 1,005
Adaptive Immune System 939 | 939
Disease 856 | 856
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 804 | 804
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 669 | 669
Membrane Trafficking 608 | 608
Cell Cycle 573 | 573
Axon guidance 542 | 542
Neutrophil degranulation 542 | 542
Signaling by Interleukins 501 | 501
Cell Cycle, Mitotic 471 | 471
Signalling by NGF 468 | 468
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 436 | 436
Class I MHC mediated antigen p... 431 | 431
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 424 | 424
Cellular responses to stress 416 | 416
DAP12 interactions 410 | 410
Infectious disease 392 | 392
NGF signalling via TRKA from t... 379 | 379
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 368 | 368
Diseases of signal transductio... 360 | 360
Signaling by EGFR 356 | 356
Transcriptional Regulation by ... 356 | 356
Metabolism of amino acids and ... 354 | 354
DAP12 signaling 347 | 347
Downstream signal transduction 344 | 344
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 330 | 330
Signaling by SCF-KIT 328 | 328
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 322 | 322
FCERI mediated MAPK activation 317 | 317
Signaling by Insulin receptor 313 | 313
Antigen processing: Ubiquitina... 302 | 302
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 291 | 291
Signaling by Wnt 291 | 291
IGF1R signaling cascade 290 | 290
IRS-related events triggered b... 290 | 290
Insulin receptor signalling ca... 289 | 289
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 286 | 286
MAPK family signaling cascades 284 | 284
Signaling by the B Cell Recept... 283 | 283
Asparagine N-linked glycosylat... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 278 | 278
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 269 | 269
M Phase 267 | 267
Interleukin-3, 5 and GM-CSF si... 263 | 263
RET signaling 262 | 262
Signalling to ERKs 255 | 255
Interleukin-2 signaling 254 | 254
Immunoregulatory interactions ... 252 | 252
VEGFR2 mediated cell prolifera... 250 | 250
RHO GTPase Effectors 249 | 249
Signalling to RAS 248 | 248
Interleukin receptor SHC signa... 247 | 247
G alpha (i) signalling events 245 | 245
Signaling by Leptin 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Prolonged ERK activation event... 244 | 244
MAPK1/MAPK3 signaling 243 | 243
Frs2-mediated activation 242 | 242
HIV Infection 242 | 242
ARMS-mediated activation 241 | 241
Signalling to p38 via RIT and ... 241 | 241
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 237 | 237
RAF/MAP kinase cascade 237 | 237
SHC1 events in EGFR signaling 237 | 237
SOS-mediated signalling 237 | 237
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Ub-specific processing proteas... 203 | 203

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
60S ribosomal protein L7a RPL7A Tbio Non-IDG -1.66015 45.9 60
60S ribosomal protein L18 RPL18 Tbio Non-IDG -1.73537 50.7 134
60S ribosomal protein L38 RPL38 Tdark Non-IDG -1.39563 24.2 45
Ubiquitin-60S ribosomal protein L40 UBA52 Tbio Non-IDG -2.21113 124.2 150
40S ribosomal protein S4, Y isoform 1 RPS4Y1 Tbio Non-IDG -1.22796 15.4 118
60S ribosomal protein L8 RPL8 Tbio Non-IDG -1.56871 36.4 182
40S ribosomal protein S3 RPS3 Tbio Non-IDG -2.16121 152.6 207
60S ribosomal protein L39 RPL39 Tbio Non-IDG 18.8 114
60S ribosomal protein L31 RPL31 Tbio Non-IDG -1.26053 17.9 99
60S ribosomal protein L32 RPL32 Tbio Non-IDG -2.15191 130.7 62